ECS Botanics Archives | Page 10 of 11 | Cannabiz

Company news: Helius Therapeutics; ECS Botanics; Opticann; Releaf Group; Greenfern Industries

by Martin Lane October 12, 2021April 29, 2024

Helius Therapeutics New Zealand medicinal cannabis company Helius Therapeutics has appointed Candace Kinser as its new […]

Company news: ECS Botanics; Cann Group; Medlab Clinical; Medibis

by Martin Lane September 8, 2021April 26, 2024

Roby Zomer

Company news: MGC Pharma; Emyria; ECS Botanics; Rua Bioscience; AusCann; Cannasouth; Cronos; Althea

by Martin Lane September 2, 2021April 26, 2024

Company news: TCann; ECS Botanics; Cannaponics; Releaf Group; Cannvalate; Elixinol; Creso Pharma; Incannex

by Martin Lane August 19, 2021April 26, 2024

ECS Botanics signs A$4.5 million Polish supply deal

by Martin Lane July 26, 2021April 26, 2024

Company news: Cann Global; ANTG/Asterion; ECS Botanics; AusCann; Creso Pharma

by Martin Lane July 5, 2021April 26, 2024

ECS Botanics forecasts sales of A$2 million in 2021

by Martin Lane June 9, 2021April 26, 2024

Company news: Lifespot Health; Oxford Cannabinoid Technologies; ECS Botanics; Creso Pharma

by Martin Lane May 21, 2021April 26, 2024

ECS Botanics ships first commercial medicinal cannabis from north-west Victoria facility

by Martin Lane April 19, 2021April 26, 2024

ECS Botanics plans major expansion in Tasmania

by Martin Lane April 15, 2021April 26, 2024